Overview
Classic multiminicore myopathy, also known as classic multiminicore disease (MmD), is a rare inherited muscle disorder that belongs to a group of conditions called congenital myopathies. The name comes from the appearance of muscle tissue under a microscope, which shows many small areas of damage called "minicores" within the muscle fibers. These minicores represent regions where the normal internal structure of the muscle cell has broken down. The disease primarily affects the muscles used for movement and breathing. People with classic multiminicore myopathy typically experience widespread muscle weakness, particularly in the trunk and limbs. The weakness tends to be more prominent in muscles closer to the center of the body, such as the hips and shoulders. A hallmark feature is significant weakness of the muscles between the ribs, which can lead to breathing difficulties. Many affected individuals also develop scoliosis (curvature of the spine), which can worsen over time and further compromise breathing. Symptoms usually appear in infancy or early childhood. Babies may seem floppy (hypotonic) and may have difficulty feeding. Motor milestones like sitting and walking are often delayed. While the muscle weakness is generally not progressive or only slowly progressive, the breathing problems and scoliosis can become serious concerns that require ongoing medical attention. There is currently no cure for classic multiminicore myopathy, and treatment focuses on managing symptoms through physical therapy, respiratory support, and orthopedic interventions for scoliosis. With proper care, many individuals can maintain a reasonable quality of life, though the severity varies from person to person.
Also known as:
Key symptoms:
Muscle weakness, especially in the trunk, hips, and shouldersFloppy or low muscle tone in infancyBreathing difficulties due to weak chest musclesScoliosis (curvature of the spine)Rigid or stiff spineDelayed motor milestones such as sitting and walkingDifficulty with feeding in infancyPoor head control in babiesThin or underdeveloped musclesReduced ability to exercise or keep up with peersJoint stiffness or contracturesNighttime breathing problems or sleep apneaFatigue with physical activity
Clinical phenotype terms (29)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Classic multiminicore myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Classic multiminicore myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Classic multiminicore myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Classic multiminicore myopathy.
Community
No community posts yet. Be the first to share your experience with Classic multiminicore myopathy.
Start the conversation →Latest news about Classic multiminicore myopathy
No recent news articles for Classic multiminicore myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my child's muscle weakness, and what level of function can we expect over time?,How often should breathing and lung function be tested?,When should we consider non-invasive ventilation or other respiratory support?,What signs of scoliosis progression should I watch for, and when might surgery be needed?,What physical therapy program is best suited for this condition?,Should genetic testing be offered to other family members or for future pregnancies?,Are there any clinical trials or emerging treatments we should know about?
Common questions about Classic multiminicore myopathy
What is Classic multiminicore myopathy?
Classic multiminicore myopathy, also known as classic multiminicore disease (MmD), is a rare inherited muscle disorder that belongs to a group of conditions called congenital myopathies. The name comes from the appearance of muscle tissue under a microscope, which shows many small areas of damage called "minicores" within the muscle fibers. These minicores represent regions where the normal internal structure of the muscle cell has broken down. The disease primarily affects the muscles used for movement and breathing. People with classic multiminicore myopathy typically experience widespread
How is Classic multiminicore myopathy inherited?
Classic multiminicore myopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Classic multiminicore myopathy typically begin?
Typical onset of Classic multiminicore myopathy is infantile. Age of onset can vary across affected individuals.